SCHEMBL28094972

SCHEMBL28094972

NCc1ccc(-c2ccc(C(=O)NC3C4CC5CC3CC(C(N)=O)(C5)C4)o2)cc1

nearest known ligand 0.47

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ GPR55 Q9Y2T6 1/20 0.47
▸ HSD11B1 P28845 18/20 0.46
▸ HSD11B2 P80365 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14157654 0.90 NPC1 (0.58) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL15706755 0.90 HSD11B1 (0.54) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL15706769 0.90 NPC1 (0.58) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL14157597 0.90 HSD11B1 (0.54) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL14157555 0.90 HSD11B1 (0.48) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL15706806 0.90 HSD11B1 (0.48) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL15706726 0.89 HSD11B1 (0.54) HSD11B1HSD11B2
SCHEMBL14157716 0.89 HSD11B1 (0.54) HSD11B1HSD11B2
SCHEMBL15706730 0.88 HSD11B1 (0.60) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL14157623 0.88 HSD11B1 (0.60) KDM4ENPC1ALDH1A1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103649066-B 5-carbamyl-diamantane (obsolete)-2-yl amide derivatives, its pharmaceutically acceptable salt and preparation method thereof 爱思开生物制药株式会社 2016-08-17 — — CN claimed
CN-103649066-B 5-carbamyl-diamantane (obsolete)-2-yl amide derivatives, its pharmaceutically acceptable salt and preparation method thereof 爱思开生物制药株式会社 2016-08-17 — — CN disclosed
Send feedback